Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05832307 · ClinicalTrials.gov registry record · NA

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

A NA study of Influenza, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
22,000
Enrollment target
2
Study locations

NCT05832307: Recruiting NA study of Influenza, sponsored by University of Colorado, Denver.

NCT05832307 is a NA study of Influenza that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 22,000 participants, below the 36,663-participant average among 156 other Influenza trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05832307, a NA study of Influenza, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
22,000 participants
Enrollment target
2
Study locations

Study Summary

This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.

Primary Outcome

proportion of influenza vaccine administrations to eligible patients during hospitalization.

Conditions Studied

Interventions

  • OTHER Existing Influenza Vaccination Practices
  • OTHER Standardized inpatient influenza vaccination program

Study Locations (2)

Illinois

  • Ann and Robert Lurie's Children Hospital of Chicago - Chicago

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 22,000 participants
Start Date 2024-10-31
Est. Completion 2027-07-31
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT05832307 shows while recruiting

NCT05832307 is an interventional study that assigns participants to a tested intervention. Its 22,000 participants enrollment target places it among the larger protocols in the corpus, below the 36,663-participant average among 156 other Influenza trials with a reported enrollment target (40% lower).

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Existing Influenza Vaccination Practices is the first listed.

NCT05832307 reports a single indexed study location in Illinois, Washington.

Frequently Asked Questions

What is clinical trial NCT05832307 about?

NCT05832307 is a clinical study titled "The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program". This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, incl...

What is the current status of trial NCT05832307?

This trial is currently recruiting. It is a NA study. The enrollment target is 22,000 participants. The study started on 2024-10-31. Estimated completion is 2027-07-31.

What conditions does trial NCT05832307 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT05832307?

The interventions under investigation include: Existing Influenza Vaccination Practices (OTHER), Standardized inpatient influenza vaccination program (OTHER).

Who is sponsoring clinical trial NCT05832307?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05832307 being conducted?

This trial has 2 study locations across Illinois, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05832307's enrollment target sits among peer trials

22,000 9th of 156 higher than 148 of 156 other Influenza trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05488080 · 22,032 participants · NA

    PAINED: Project Addressing INequities in the Emergency Department

  • NCT07413211 · 22,068 participants

    Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

  • NCT06486688 · 22,320 participants · NA

    Centralized Virtual SBIRT for Pediatric Primary Care

  • NCT06047041 · 21,350 participants · NA

    Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05832307, the US trial registry maintained by the National Library of Medicine. NCT05832307 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.